rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Justin J. Noznesky

Chief Mktg & Strategy Officer

Company insider

Files Form 4 as: Chief Mktg & Strategy Officer, AtriCure.

In numbers

Trades disclosed
71
Buys
0
Sells
18
Bought
$0
Sold
$7.2M
Companies
1
Companies where not an officer
0
First trade
1 Mar 2016
Last trade
29 Jul 2026
Last filed
30 Jul 2026

Companies traded

Where they are an officer
ATRC AtriCureOfficer · Medical Devices · last 29 Jul 20260 buys · 18 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 Jul 2026filed 30 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$240K6,182 at $38.80filing
29 Jul 2026filed 30 Jul 2026ATRC AtriCureMedical DevicesSEC FORM 4 Sold$240K6,182 at $38.80filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—27,991 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$487K15,586 at $31.26filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—27,991 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code A—15,198 at $0.00filing
1 Mar 2026filed 3 Mar 2026ATRC AtriCureMedical DevicesSEC FORM 4 Code F$487K15,586 at $31.26filing
26 Nov 2025filed 26 Nov 2025ATRC AtriCureMedical DevicesSEC FORM 4 Sold$193K5,166 at $37.29filing
12 Sep 2025filed 16 Sep 2025ATRC AtriCureMedical DevicesSEC FORM 4 Sold$109K3,000 at $36.30filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—19,359 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code A—6,579 at $0.00filing
1 Mar 2025filed 4 Mar 2025ATRC AtriCureMedical DevicesSEC FORM 4 Code F$375K9,673 at $38.74filing
11 Dec 2024filed 12 Dec 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code G—585 at $0.00filing
1 May 2024filed 3 May 2024ATRC AtriCureMedical DevicesSEC FORM 4 Sold$36K1,500 at $24.09filing
1 Apr 2024filed 3 Apr 2024ATRC AtriCureMedical DevicesSEC FORM 4 Sold$46K1,500 at $30.39filing
12 Mar 2024filed 14 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Sold$55K1,500 at $36.72filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—19,294 at $0.00filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code A—9,328 at $0.00filing
1 Mar 2024filed 5 Mar 2024ATRC AtriCureMedical DevicesSEC FORM 4 Code F$321K8,856 at $36.28filing

News

Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026

0 headlines in the last 90 days name Justin J. Noznesky; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care18

Buys in green, sells in red, by the company’s sector.

Related people

Salvatore PriviteraChief Technical Officer · Chief Technical Officer at AtriCure, filing Form 4 there in the last year
Regina E. GrovesDirector · Director at AtriCure, filing Form 4 there in the last year
Karl S. DahlquistChief Legal Officer · Chief Legal Officer at AtriCure, filing Form 4 there in the last year
Maggie YuenDirector · Director at AtriCure, filing Form 4 there in the last year
Karen PrangeDirector · Director at AtriCure, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded ATRC in the last 90 days
Sven WehrweinDirector · Also traded ATRC in the last 90 days
Vinayak DoraiswamyChief Scientific Officer · Also traded ATRC in the last 90 days